Barriers and Facilitators to Vaccine Equity Amidst the COVID-19 Vaccine Rollout in the United States
2024

Barriers and Facilitators to Vaccine Equity During COVID-19 in the U.S.

Sample size: 16 publication Evidence: moderate

Author Information

Author(s): Piltch-Loeb Rachael, Nuñez Sahr Josefina, Nelson LaRon E., Vlahov David, Gershon Robyn R.

Primary Institution: Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY)

Hypothesis

What are the challenges and strategies in achieving vaccine equity for hard-to-reach populations during the COVID-19 vaccine rollout?

Conclusion

Community engagement is crucial for ensuring equitable vaccine distribution.

Supporting Evidence

  • Community engagement was identified as a key factor in promoting vaccine equity.
  • Barriers included lack of clarity on vaccine prioritization and language access issues.
  • Mass vaccination sites often did not meet the needs of vulnerable populations.

Takeaway

This study shows that working with local communities helps people get vaccinated, especially those who might have trouble accessing vaccines.

Methodology

Qualitative study using semi-structured interviews with stakeholders from health departments across nine states.

Potential Biases

Potential bias due to the political leanings of the states represented.

Limitations

Findings may not be generalizable beyond the nine states studied, which are predominantly politically left-leaning.

Participant Demographics

Participants included 16 individuals from health departments in nine U.S. states, holding leadership roles in vaccine distribution.

Digital Object Identifier (DOI)

10.3390/ijerph21121588

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication